Biosplice
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9360 Towne Centre Dr, San Diego, Califor...Phone Number
(858) 926-2900Website
www.biosplice.comRevenue
$26 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Biosplice
Based in San Diego, CA, Biosplice is developing small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing.Explore more
Biosplice Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biosplice your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Biosplice
Product Launch: Get notified when Biosplice launches new products
Biosplice, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Biosplice recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Biosplice is spiking on competitors!
Funding: Get notified immidiatlly once Biosplice has new funding data
Check if Biosplice has recently received funding, and reach out quickly before it becomes old news!
Click to see if Biosplice had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Biosplice as Masked Content
Find 3 more new buyers
Compare Similar Companies to Biosplice
Compare insights from companies similar to Biosplice, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
Biosplice is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biosplice is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biosplice.
Biosplice financials insights
Gather financial insights about Biosplice, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$120M
Biosplice Tech Stack
A closer look at the technologies used by Biosplice
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Biosplice News & Media
Biosplice Therapeutics Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD Platinum‑Resistant Ovarian Cancer
Biosplice Announces First Patient Dosed in Investigator‑Initiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in Ovarian CancerBiosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Multicenter study sponsored by the National Cancer InstituteBiosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue SarcomasBiosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
Biosplice Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biosplice
Sign Up For FreeTo access detailed company insights
Based in San Diego, CA, Biosplice is developing small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing.... Read More
